BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29779223)

  • 41. Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries.
    Metzakopian E; Strong A; Iyer V; Hodgkins A; Tzelepis K; Antunes L; Friedrich MJ; Kang Q; Davidson T; Lamberth J; Hoffmann C; Davis GD; Vassiliou GS; Skarnes WC; Bradley A
    Sci Rep; 2017 May; 7(1):2244. PubMed ID: 28533524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Supramolecular nanosubstrate-mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies.
    Yang P; Chou SJ; Li J; Hui W; Liu W; Sun N; Zhang RY; Zhu Y; Tsai ML; Lai HI; Smalley M; Zhang X; Chen J; Romero Z; Liu D; Ke Z; Zou C; Lee CF; Jonas SJ; Ban Q; Weiss PS; Kohn DB; Chen K; Chiou SH; Tseng HR
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33097539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics, Recombination Methods, and Applications Progresses of Split-Cas9 System.
    Liu Z; Huang L; Deng H; Chen Y; Xiao H
    Hum Gene Ther; 2023 Jul; 34(13-14):594-604. PubMed ID: 37265143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of Functional Gene Knockout Melanoma Cell Lines by CRISPR-Cas9 Gene Editing.
    Hargadon KM; Bushhouse DZ; Johnson CE; Williams CJ
    Methods Mol Biol; 2021; 2265():25-46. PubMed ID: 33704703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optogenetic studies of nicotinic contributions to cholinergic signaling in the central nervous system.
    Jiang L; López-Hernández GY; Lederman J; Talmage DA; Role LW
    Rev Neurosci; 2014; 25(6):755-71. PubMed ID: 25051276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRISPR/Cas9-mediated knockin of IRES-tdTomato at Ins2 locus reveals no RFP-positive cells in mouse islets.
    Zhou X; Fu Q; Yang T; Sun M
    Funct Integr Genomics; 2023 Jan; 23(1):42. PubMed ID: 36652148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conditional Single Vector CRISPR/SaCas9 Viruses for Efficient Mutagenesis in the Adult Mouse Nervous System.
    Hunker AC; Soden ME; Krayushkina D; Heymann G; Awatramani R; Zweifel LS
    Cell Rep; 2020 Mar; 30(12):4303-4316.e6. PubMed ID: 32209486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae.
    Zhao X; Jin C; Dong T; Sun Z; Zheng X; Feng B; Cheng Z; Li X; Tao Y; Wu H
    Hear Res; 2020 Sep; 394():107999. PubMed ID: 32611519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.
    Mangeot PE; Risson V; Fusil F; Marnef A; Laurent E; Blin J; Mournetas V; Massouridès E; Sohier TJM; Corbin A; Aubé F; Teixeira M; Pinset C; Schaeffer L; Legube G; Cosset FL; Verhoeyen E; Ohlmann T; Ricci EP
    Nat Commun; 2019 Jan; 10(1):45. PubMed ID: 30604748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma.
    Peixoto J; Príncipe C; Pestana A; Osório H; Pinto MT; Prazeres H; Soares P; Lima RT
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511044
    [No Abstract]   [Full Text] [Related]  

  • 51. Fast, multiplexable and efficient somatic gene deletions in adult mouse skeletal muscle fibers using AAV-CRISPR/Cas9.
    Thürkauf M; Lin S; Oliveri F; Grimm D; Platt RJ; Rüegg MA
    Nat Commun; 2023 Sep; 14(1):6116. PubMed ID: 37777530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell specific single viral vector CRISPR/Cas9 editing and genetically encoded tool delivery in the central and peripheral nervous systems.
    Moffa JC; Bland IN; Tooley JR; Kalyanaraman V; Heitmeier M; Creed MC; Copits BA
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adeno-associated virus vector enables safe and efficient Cas9 activation in neonatal and adult Cas9 knockin murine cochleae.
    Kang W; Zhao X; Sun Z; Dong T; Jin C; Tong L; Zhu W; Tao Y; Wu H
    Gene Ther; 2020 Aug; 27(7-8):392-405. PubMed ID: 32005950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of non-viral vectors for neuronal-targeted delivery of CRISPR-Cas9 RNA-proteins as a therapeutic strategy for neurological disorders.
    Shalaby KE; Aouida M; Gupta V; Abdesselem H; El-Agnaf OMA
    Biomater Sci; 2022 Aug; 10(17):4959-4977. PubMed ID: 35880637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Convenient Cas9-based Conditional Knockout Strategy for Simultaneously Targeting Multiple Genes in Mouse.
    Chen J; Du Y; He X; Huang X; Shi YS
    Sci Rep; 2017 Mar; 7(1):517. PubMed ID: 28364122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
    Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission.
    Wu M; Robinson JE; Joiner WJ
    Curr Biol; 2014 Mar; 24(6):621-9. PubMed ID: 24613312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Construction of all-in-one CRISPR/Cas9 vector system targeting miR-101a gene in mouse hepatic cell line AML12].
    Chen D; Li Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 46(4):427-432. PubMed ID: 29256233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient CRISPR/Cas9 mediated Pooled-sgRNAs assembly accelerates targeting multiple genes related to male sterility in cotton.
    Ramadan M; Alariqi M; Ma Y; Li Y; Liu Z; Zhang R; Jin S; Min L; Zhang X
    Plant Methods; 2021 Feb; 17(1):16. PubMed ID: 33557889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver.
    Sago CD; Lokugamage MP; Loughrey D; Lindsay KE; Hincapie R; Krupczak BR; Kalathoor S; Sato M; Echeverri ES; Fitzgerald JP; Gan Z; Gamboa L; Paunovska K; Sanhueza CA; Hatit MZC; Finn MG; Santangelo PJ; Dahlman JE
    Nat Biomed Eng; 2022 Feb; 6(2):157-167. PubMed ID: 35190679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.